Wick W - Search Results

1

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ. Wen PY, et al. Among authors: wick w. Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106. Neuro Oncol. 2020. PMID: 32328653 Free PMC article. Review.

2

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

Fulda S, Wick W, Weller M, Debatin KM. Fulda S, et al. Among authors: wick w. Nat Med. 2002 Aug;8(8):808-15. doi: 10.1038/nm735. Epub 2002 Jul 15. Nat Med. 2002. PMID: 12118245

3

Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.

Wick W, Hermisson M, Kortmann RD, Küker WM, Duffner F, Dichgans J, Bamberg M, Weller M. Wick W, et al. J Neurooncol. 2002 Sep;59(2):151-5. doi: 10.1023/a:1019641314661. J Neurooncol. 2002. PMID: 12241108 Clinical Trial.

4

Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.

Rieger J, Wick W, Weller M. Rieger J, et al. Among authors: wick w. Glia. 2003 Jun;42(4):379-89. doi: 10.1002/glia.10210. Glia. 2003. PMID: 12730958

5

P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.

Bähr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W. Bähr O, et al. Among authors: wick w. Brain Pathol. 2003 Oct;13(4):482-94. doi: 10.1111/j.1750-3639.2003.tb00479.x. Brain Pathol. 2003. PMID: 14655754 Free PMC article.

6

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: wick w. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

7

Intracranial metastatic esthesioneuroblastoma responsive to temozolomide.

Wick W, Wick A, Küker W, Dichgans J, Weller M. Wick W, et al. Among authors: wick a. J Neurooncol. 2004 Oct;70(1):73-5. doi: 10.1023/b:neon.0000040826.30636.4a. J Neurooncol. 2004. PMID: 15527110

8

BCL-2-induced glioma cell invasiveness depends on furin-like proteases.

Wick W, Wild-Bode C, Frank B, Weller M. Wick W, et al. J Neurochem. 2004 Dec;91(6):1275-83. doi: 10.1111/j.1471-4159.2004.02806.x. J Neurochem. 2004. PMID: 15584904 Free article.

9

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

Uhl M, Weiler M, Wick W, Jacobs AH, Weller M, Herrlinger U. Uhl M, et al. Among authors: wick w. Biochem Biophys Res Commun. 2005 Mar 4;328(1):125-9. doi: 10.1016/j.bbrc.2004.12.164. Biochem Biophys Res Commun. 2005. PMID: 15670759

10

How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.

Wick W, Weller M. Wick W, et al. J Clin Oncol. 2005 Jun 20;23(18):4235-6; author reply 4236. doi: 10.1200/JCO.2004.00.8417. J Clin Oncol. 2005. PMID: 15961774 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page